LATEST NEWS: Trump, in Oval Office, signs first order on Obamacare - WASHINGTON (Reuters) - President Donald Trump signed his first executive order on Friday, heading into the Oval Office shortly after his inaugural parade to direct agencies to ease regulations associated with Obamacare, the signature healthcare law of his predecessor that Trump has vowed to replace.
LATEST NEWS: Merck, Bristol-Myers agree to settle Keytruda patent suit - (Reuters) - Merck & Co said it agreed to enter into a settlement and license agreement with Bristol-Myers Squibb Co and Ono Pharmaceutical Co Ltd to resolve all global patent-infringement litigation related to its cancer drug, Keytruda.
LATEST NEWS: Heartburn pills tied to serious bacterial infections - (Reuters Health) - People who take popular heartburn pills known as proton pump inhibitors (PPIs) may be more likely to develop intestinal infections than people who don’t take these medications, a Scottish study suggests.
LATEST NEWS: Are ‘natural’ cigarette smokers being misled? - (Reuters Health) - Natural American Spirit tobacco products are marketed as “natural” and “additive-free,” and many users think that means the cigarettes are safer to smoke, according to a recent U.S. study.
LATEST NEWS: Kazakhstan confirms H5 bird flu in wild swans: OIE - PARIS (Reuters) - Kazakhstan confirmed an outbreak of highly contagious H5 bird flu virus in wild swans by the Caspian Sea, the World Organisation for Animal Health (OIE) said on Friday, citing a report from the Kazakh agriculture ministry.
LATEST NEWS: Cancer patients with depression have resources - Reuters Health - Cancer patients who experience depression can use both therapy and lifestyle tools to help support their mental health, according to a new patient resource from the JAMA Oncology journal.
LATEST NEWS: Pharma CEOs in Davos put brave face on Trump presidency - DAVOS, Switzerland (Reuters) - Leaders of the global pharmaceutical industry, blasted by incoming U.S. President Donald Trump for "getting away with murder" on drug prices, are putting a brave face on the challenges in their biggest market.